EP3445388
MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.4.2017EP published:
17.4.2024EP application number:
17727373.7
EP translation filed:
27.5.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
17.4.2037Expiry date:
17.4.2027Next due date:
30.4.2027
Title in English:
MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIESLanguage of the patent:
English
Timeline
Today
18.4.2017EP application
17.4.2024EP Publication
27.5.2024Translation submitted
15.6.2024Registration published
17.4.2027Expires
Owner
Name:
Vertex Pharmaceuticals IncorporatedAddress:
50 Northern Avenue, Boston, MA 02210, US
Inventor
Name:
COWAN, Chad, AlbertAddress:
Cambridge, MA 02139, US
Name:
LUNDBERG, Ante, SvenAddress:
Cambridge, MA 02139, US
Name:
CHAKRABORTY, TirthaAddress:
Cambridge, MA 02139, US
Name:
LIN, Michelle, I-chingAddress:
Cambridge, MA 02139, US
Name:
MISHRA, Bibhu, PrasadAddress:
Cambridge, MA 02139, US
Name:
PAIK, Elizabeth, Jae-eunAddress:
Cambridge, MA 02139, US
Name:
KERNYTSKY, AndrewAddress:
Cambridge, MA 02139, US
Name:
BORLAND, Todd, DouglassAddress:
Cambridge, MA 02139, US
Priority
Number:
201662324024 PDate:
18.4.2016Country:
US
Number:
201662382522 PDate:
1.9.2016Country:
US
Number:
201662429428 PDate:
2.12.2016Country:
US
Classification
Categories:
A61K 38/46, C12N 9/22, C12N 15/10, C12N 15/113
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 17.5.2024
Expires: 17.4.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 14.4.2025
Expires: 17.4.2026
Payer: Árnason Faktor ehf.
Number: 10
Paid: 21.4.2026
Expires: 17.4.2027
Payer: Árnason Faktor ehf.